A critical cellular protection mechanism against iron-driven cell death may depend more heavily on vitamin B2 status than previously recognized. This discovery could reshape how we understand nutritional influences on cellular aging and cancer resistance. Through targeted genetic screening, investigators identified riboflavin (vitamin B2) as essential for maintaining FSP1, a protein that prevents ferroptosis—a form of regulated cell death driven by iron-dependent lipid peroxidation. When cells lack adequate riboflavin, FSP1 becomes unstable and loses its ability to recycle membrane-protective antioxidants like ubiquinone and vitamin E. This breakdown leaves cellular membranes vulnerable to oxidative damage that can trigger cell death. The research team demonstrated this relationship by depleting riboflavin or using roseoflavin, a B2 antagonist, which dramatically increased cancer cell sensitivity to ferroptosis-inducing compounds. This finding represents a significant advance in understanding how basic nutrients influence fundamental cellular defense systems. Previous ferroptosis research focused primarily on glutathione peroxidase 4 and direct antioxidant supplementation, but this work reveals riboflavin's upstream regulatory role in maintaining the entire protective network. The implications extend beyond basic cell biology to practical health considerations. Many adults have suboptimal B2 status, particularly older individuals and those following restrictive diets. If riboflavin insufficiency compromises FSP1-mediated protection, it could accelerate cellular aging and reduce natural defenses against oxidative stress. For cancer treatment, this pathway presents a double-edged opportunity: ensuring adequate B2 might protect healthy cells from oxidative damage, while targeted B2 depletion could sensitize resistant tumors to ferroptosis-based therapies. However, this represents early-stage research requiring validation in human studies before clinical applications emerge.